Gastric carcinoma. A pathobiological classification - PubMed (original) (raw)
Gastric carcinoma. A pathobiological classification
S C Ming. Cancer. 1977 Jun.
Abstract
Gastric carcinomas had various pathological features. Based on patterns of growth and invasiveness, however, they fell into two types; expanding type and infiltrative type. These types were readily recognizable histologically: expanding carcinomas grew en masse and by expansion, resulting in the formation of discrete tumor nodules, whereas in infiltrative carcinoma tumor cells invaded individuality. Both types showed varying degrees of cell maturation, but glands were much more common in expanding carcinoma. The difference in growth pattern was reflected partly by gross appearance of the tumors. These two types of carcinoma appeared to be different in their histogenetic origins. Intestinal metaplasia probably played a role in the development of expanding, but not infiltrative, carcinoma. There were differences also in the sex and age of the patients, survival rate, and epidemiological distribution. Thus, this classification provided a simple basis for evaluation of various aspects of gastric cancer.
Similar articles
- Establishment and characterization of an expanding-type gastric cancer cell line by Ming's classification.
Xu H, Peng JG, Zhuang YF, Chen JJ, Luo QC, Huang WF, Lin CD, Cai JC. Xu H, et al. Oncol Rep. 2016 Nov;36(5):3030-3036. doi: 10.3892/or.2016.5090. Epub 2016 Sep 14. Oncol Rep. 2016. PMID: 27633271 - [Does Ming's classification of gastric carcinomas have epidemiologic or prognostic value?].
Piard F, Hillon P, Levillain P, Boutron MC, Milan C, Michiels R, Faivre J. Piard F, et al. Ann Pathol. 1986;6(4-5):329-34. Ann Pathol. 1986. PMID: 3814273 French. - [Current histological classification and morphological and statistical characteristics of stomach cancer].
Zolotarevskiĭ VB, Khon ChV. Zolotarevskiĭ VB, et al. Arkh Patol. 1984;46(6):27-33. Arkh Patol. 1984. PMID: 6089710 Russian. - Classification of gastric carcinoma.
Borchard F. Borchard F. Hepatogastroenterology. 1990 Apr;37(2):223-32. Hepatogastroenterology. 1990. PMID: 2187787 Review. - Genetic pathways of two types of gastric cancer.
Tahara E. Tahara E. IARC Sci Publ. 2004;(157):327-49. IARC Sci Publ. 2004. PMID: 15055305 Review.
Cited by
- Clinicopathological significance of claudin-4 in gastric carcinoma.
Zhu JL, Gao P, Wang ZN, Song YX, Li AL, Xu YY, Wang MX, Xu HM. Zhu JL, et al. World J Surg Oncol. 2013 Jul 4;11:150. doi: 10.1186/1477-7819-11-150. World J Surg Oncol. 2013. PMID: 23822740 Free PMC article. - Histological and mutational profile of diffuse gastric cancer: current knowledge and future challenges.
Garcia-Pelaez J, Barbosa-Matos R, Gullo I, Carneiro F, Oliveira C. Garcia-Pelaez J, et al. Mol Oncol. 2021 Nov;15(11):2841-2867. doi: 10.1002/1878-0261.12948. Epub 2021 May 2. Mol Oncol. 2021. PMID: 33724653 Free PMC article. Review. - Inhibition of circRNA circVPS33B Reduces Warburg Effect and Tumor Growth Through Regulating the miR-873-5p/HNRNPK Axis in Infiltrative Gastric Cancer.
Lu Y, Cheng J, Cai W, Zhuo H, Wu G, Cai J. Lu Y, et al. Onco Targets Ther. 2021 May 12;14:3095-3108. doi: 10.2147/OTT.S292575. eCollection 2021. Onco Targets Ther. 2021. PMID: 34012268 Free PMC article. - The epidemiology of gastric cancer.
Correa P. Correa P. World J Surg. 1991 Mar-Apr;15(2):228-34. doi: 10.1007/BF01659057. World J Surg. 1991. PMID: 2031359 - Preoperative Systemic Immune-Inflammation Index (SII) for Predicting the Survival of Patients with Stage I-III Gastric Cancer with a Signet-Ring Cell (SRC) Component.
Zhu Z, Cong X, Li R, Yin X, Li C, Xue Y. Zhu Z, et al. Biomed Res Int. 2020 May 22;2020:5038217. doi: 10.1155/2020/5038217. eCollection 2020. Biomed Res Int. 2020. PMID: 32596318 Free PMC article.
MeSH terms
LinkOut - more resources
Other Literature Sources
Research Materials